Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil. Lee GH, Guzman AK, Divito SJ, Soiffer RJ, et al. N Engl J Med 2023;389:188-190.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee GH, Guzman AK, Divito SJ, Soiffer RJ, et al. Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil. N Engl J Med 2023;389:188-190.
PMID: 37437151